Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's MetLife, Inc. (MET) position

Yes: as of Q1 2026, Jim Simons holds 15K shares of MET worth $1.0M (0.0% of the disclosed portfolio). Last quarter the position was reduced by 4.5%. First disclosed Q2 2022.
View full portfolio →
Current value
$1.0M
Shares held
15K
% of portfolio
0.0%
Est. average buy price (i)
$79.69
Quarter-end price
$70.72

Estimated trade prices

Average price in quarters with purchases
$74.21
Average prices in quarters with sales
  • Q1 2026: $74.87 (700 shares sold)
  • Q4 2025: $79.14 (430K shares sold)
  • Q1 2023: $67.49 (702K shares sold)

MET price vs Simons's position

1Y 3Y 5Y MAX
Dates
$40$60$80$100202420252026New position of 100K shares · Q3 2024. Average closing price $74.70 · Price range $67.96–$82.48100KsharespurchasedNew position of 184K shares · Q1 2025. Average closing price $83.17 · Price range $77.70–$87.00184KsharespurchasedAdded 248K shares (135.1%) · Q2 2025. Average closing price $77.17 · Price range $68.42–$82.49248KsharespurchasedAdded 13K shares (3.1%) · Q3 2025. Average closing price $78.69 · Price range $73.82–$82.3713KsharespurchasedSold 430K shares (96.5%) · Q4 2025. Average closing price $79.14 · Price range $73.92–$82.89430KsharessoldSold 700 shares (4.5%) · Q1 2026. Average closing price $74.87 · Price range $67.70–$81.77700sharessold← Earlier —2 purchases, 1 sell
Average closing price · filing quarter
$74.87
Price range · filing quarter
$67.70 – $81.77
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −700 −$52K −4.5% 15K May 14, 2026
Q4 2025 Reduced −430K −$34M −96.5% 15K Feb 12, 2026
Q3 2025 Added +13K +$1.0M +3.1% 445K Nov 13, 2025
Q2 2025 Added +248K +$19M +135.1% 432K Aug 13, 2025
Q1 2025 New +184K +$15M – 184K May 14, 2025
Q3 2024 New +100K +$7.4M – 100K Nov 13, 2024
Q1 2023 Reduced −702K −$47M −91.9% 62K May 12, 2023
Q4 2022 New +764K +$55M – 764K Feb 13, 2023
Q2 2022 New +65K +$4.3M – 65K Aug 12, 2022
Data through Q1 2026 · filed May 14, 2026
9 grouped rows from 9 quarters

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own MET?

Yes. As of Q1 2026, Jim Simons disclosed 15K shares of MET, worth $1.0M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy MET?

Jim Simons first disclosed a MET position in Q2 2022; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell MET?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in MET. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of MET does Jim Simons own?

Jim Simons disclosed 15K shares of MET as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for MET?

Jim Simons's estimated average buy price for MET is $79.69, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.